Crossmark

Is the combinational administration of doxorubicin and glutathione a reasonable proposal?

Crossref DOI link: https://doi.org/10.1038/s41401-018-0158-8

Published Online: 2018-09-14

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Bo-yu

Chen, Chong

Xu, Yang-fan

Shen, Jia-jia

Guo, Hui-min

Li, Hao-feng

Li, Xi-nuo

Kang, Dian

Shao, Yu-hao

Zhu, Zhang-pei

Yin, Xiao-xi

Xie, Lin

Wang, Guang-ji

Liang, Yan
License Information

Text and Data Mining valid from 2018-09-14
More Information

Article History

Received: 6 June 2018

Accepted: 25 July 2018

First Online: 14 September 2018

Conflict of interest

: We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.